We recently published a list of Jim Cramer Discussed 10 Stocks Leading the Dow Higher in 2025. In this article, we are going ...
Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis ...
Titan America SA ("Titan America"), a subsidiary of Titan Cement International SA and parent company of its U.S. operations, ...
Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current ...
Citi and UBS has issued calls that gold will hit US$3000/oz as the price of bullion smashes records over and over.
Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides to treat obesity, ...
The offering of the notes is scheduled to close on February 11, 2025, subject to satisfaction of customary closing conditions. T-Mobile USA intends to use the net proceeds from the offering for ...
PennyMac Mortgage Investment Trust (NYSE: PMT) (the "Company" or "PMT") today announced that it is commencing an underwritten public offering of senior notes due 2030 (the "Notes"). The Notes will be ...
SAN FRANCISCO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on ...
Goldman Sachs Group Inc. (NYSE:GS), currently trading near its 52-week high at $640.40 with a market capitalization of $216 billion, has filed a Form 8-K with the Securities and Exchange Commission ...